Scientists Turn Hookworms Into Living Pharmacies That Can Deliver Medicine From Inside Humans

It's just crazy enough to work.

We already live in symbiosis with bacteria — why not take it a step further?

In a groundbreaking new study, researchers modified a human hookworm and got it to manufacture and secrete functional human antibodies inside a living host. As a proof of concept, they engineered the worms to secrete a human antibody that neutralizes tetrodotoxin (TTX), a deadly, weaponizable neurotoxin with no known commercial antidote.

But this exciting new approach paves the way for all sorts of injection-free biologic drug delivery.

Worm Pharmacy

When you think of a hookworm, “pharmaceutical factory” probably isn’t the first phrase that comes to mind. For centuries, these persistent parasites have been viewed strictly as vectors of disease, parasites that trick our immune systems. But in the world of modern biotechnology, the resilience of these hookworms and their ability to live quietly inside a host for years while keeping the immune system at bay are useful traits.

“The hookworm has spent millions of years perfecting how to assure long-term survival inside a human host and how to get molecules out of its body and into ours,” said senior author Makedonka Mitreva, Ph.D., the Gordon R. Miller Professor at the John T. Milliken Department of Medicine’s Division of Infectious Diseases at WashU Medicine. “We asked: What if we could add one more molecule to the roughly 1,000 things the worm already secretes, something therapeutically useful to people?”

The hookworm’s entire shtick is to survive inside mammal hosts without causing a massive uproar. So, they’re stealthy and can quietly live inside the human gut for years. In fact, doctors already use controlled human infections with hookworms in clinical settings.

Researchers use them to treat chronic inflammatory conditions like celiac disease or ulcerative colitis. The idea is that some of the anti-inflammatory molecules the worms secrete can dampen the immune responses that drive those conditions. Mitreva’s team set out to build on that foundation and bioengineer the worm to secrete a therapeutic of the researchers’ choosing.

The Genetic Scissors

Modifying a parasitic worm is famously difficult.

Unlike simple bacteria or fruit flies, nematodes (worms) have a thick cuticle that protects them from external tools and shields them from the host’s immune system. They also have large, highly complex genomes that scientists have historically struggled to understand. Traditional gene-knockdown techniques were efficient only sometimes. To break through this biological fortress, the research team deployed CRISPR/Cas9, the famous molecular scissors, but with a highly strategic twist.

×

Get smarter every day...

Stay ahead with ZME Science and subscribe.

Daily Newsletter
The science you need to know, every weekday.

Weekly Newsletter
A week in science, all in one place. Sends every Sunday.
No spam, ever. Unsubscribe anytime. Review our Privacy Policy.

Thank you! One more thing...

Please check your inbox and confirm your subscription.

First, they needed to find a “safe harbor” in the worm’s genome. Basically, a place where they could insert a new gene without accidentaly disrupting the worm’s survival and welbeing. Using a massive multi-omics computational analysis tracking all 18,776 genes in the hookworm genome, they tracked down an ideal location called GSH2. This region is nestled right next to highly active genes that stay turned on across the worm’s entire life cycle.

RelatedPosts

Researchers develop nanospears that can transport DNA to cells with pinpoint accuracy
Archaeologists Found 16 Ancient Canoes Beneath a Wisconsin Lake, Some Older Than the Pyramids
Scientists Create “Bait” to Lure Baby Corals Back to Dying Reefs
The rogue Chinese scientist who made the first gene-edited human babies could face death penalty

Inside this safe harbor, the team inserted a synthetic genetic cassette. The payload was a gene coding for s16-HuScFv, a human single-chain variable fragment antibody. This specific antibody targets tetrodotoxin, a neurotoxin in pufferfish that causes total organ paralysis and death by blocking voltage-gated sodium channels in nerve cells. Currently, there is no commercial antidote available for TTX poisoning.

To make sure the worm didn’t just hoard the antibody inside its own body, the scientists attached a specialized “signal peptide” called ASP-1. This acts like a cellular shipping label, forcing the worm’s cells to pump the antibody directly out into its cocktail of secretions.

The team then tested this system on Syrian golden hamsters. The results were a resounding success.

“This study shows that’s not just a concept. It works,” Mitreva added.

Much Better Than It Sounds

The idea of having a colony of small worms inside you, each equipped with different drugs, might not seem that appealing. But there are biological guardrails that ensure this can’t go wrong.

First, hookworms can’t reproduce inside an infected host. Their eggs must hatch and mature in the outside environment before becoming infective again. This means the “dosage” of the therapeutic antibody can be precisely calibrated by controlling the exact number of larvae introduced during the initial infection.

Second, if a patient ever needs to stop the treatment, there is an incredibly simple safety valve: a single, inexpensive oral dose of standard anti-parasitic medication (like albendazole) completely wipes out the parasites.

The option is tantalizing. You can theoretically swap out the tetrodotoxin antibody gene for almost any therapeutic protein, hormone, or biological molecule of interest. This opens up a dazzling new paradigm for treating chronic human diseases. You could have a living biofactory inside you that constantly releases insulin for diabetics, anti-inflammatory proteins for patients with severe autoimmune conditions, or desensitizing allergens to cure life-altering food allergies and celiac disease directly from within the host.

There’s also a remarkably deep history to this type of modifcation. Billions of years ago, mitochondria originated from free-living bacteria that entered early eukaryotic cells in a mutually beneficial relationship. Over time, these bacteria transferred many of their genes to the host and became permanent organelles. Similarly, engineered hookworms could one day transform from parasites into internal allies, providing continuous therapeutic benefits while living safely within a human host.

The fact that we could do something like this ourselves is absolutely stunning. Therapeutic worms might not come today or tomorrow, but the promise is worth investigating.

The study was published in Nature Communications.